Sk Biopharmaceutica (Korea) Price on April 11, 2024

326030 Stock   102,100  1,500  1.45%   
If you're considering investing in 326030 Stock, it is important to understand the factors that can impact its price. As of today, the current price of Sk Biopharmaceutica stands at 102,100, as last reported on the 23rd of December, with the highest price reaching 103,600 and the lowest price hitting 99,700 during the day. Sk Biopharmaceuticals retains Efficiency (Sharpe Ratio) of -0.0291, which indicates the firm had a -0.0291% return per unit of price deviation over the last 3 months. Sk Biopharmaceutica exposes twenty-nine different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please validate Sk Biopharmaceutica's Mean Deviation of 2.21, downside deviation of 2.55, and Risk Adjusted Performance of 0.014 to confirm the risk estimate we provide.
  
326030 Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.0291

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns326030

Estimated Market Risk

 2.94
  actual daily
26
74% of assets are more volatile

Expected Return

 -0.09
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.03
  actual daily
0
Most of other assets perform better
Based on monthly moving average Sk Biopharmaceutica is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Sk Biopharmaceutica by adding Sk Biopharmaceutica to a well-diversified portfolio.

Sk Biopharmaceutica Valuation on April 11, 2024

It is possible to determine the worth of Sk Biopharmaceutica on a given historical date. On April 11, 2024 326030 was worth 87600.0 at the beginning of the trading date compared to the closed value of 87900.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Sk Biopharmaceutica stock. Still, in general, we apply an absolute valuation method to find Sk Biopharmaceutica's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Sk Biopharmaceutica where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Sk Biopharmaceutica's related companies.
 Open High Low Close Volume
  89,000    89,700    87,600    88,400    65,436  
04/11/2024
  87,600    88,400    85,700    87,900    132,846  
  87,600    87,900    86,200    86,700    77,660  
Backtest Sk Biopharmaceutica  |  Sk Biopharmaceutica History  |  Sk Biopharmaceutica Valuation   PreviousNext  
Open Value
87600.0
87,591
Downside
87900.0
Closing Value
87,609
Upside

Sk Biopharmaceutica Trading Date Momentum on April 11, 2024

On April 12 2024 Sk Biopharmaceuticals Co was traded for  86,700  at the closing time. The highest price during the trading period was 87,900  and the lowest recorded bid was listed for  86,200 . The volume for the day was 77.7 K. This history from April 12, 2024 contributed to the next trading day price decline. The daily price change to the next closing price was 1.37% . The trading price change to the current price is 3.64% .

Sk Biopharmaceuticals Fundamentals Correlations and Trends

By evaluating Sk Biopharmaceutica's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Sk Biopharmaceutica's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. 326030 financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Sk Biopharmaceutica Stock history

Sk Biopharmaceutica investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for 326030 is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Sk Biopharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Sk Biopharmaceutica stock prices may prove useful in developing a viable investing in Sk Biopharmaceutica

Sk Biopharmaceutica Stock Technical Analysis

Sk Biopharmaceutica technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Sk Biopharmaceutica technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Sk Biopharmaceutica trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Sk Biopharmaceutica Period Price Range

Low
December 23, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Sk Biopharmaceuticals Co cannot be verified against its exchange. Please verify the symbol is currently traded on Korea Stock Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Sk Biopharmaceutica December 23, 2024 Market Strength

Market strength indicators help investors to evaluate how Sk Biopharmaceutica stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Sk Biopharmaceutica shares will generate the highest return on investment. By undertsting and applying Sk Biopharmaceutica stock market strength indicators, traders can identify Sk Biopharmaceuticals Co entry and exit signals to maximize returns

Sk Biopharmaceutica Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Sk Biopharmaceutica's price direction in advance. Along with the technical and fundamental analysis of 326030 Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of 326030 to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Complementary Tools for 326030 Stock analysis

When running Sk Biopharmaceutica's price analysis, check to measure Sk Biopharmaceutica's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sk Biopharmaceutica is operating at the current time. Most of Sk Biopharmaceutica's value examination focuses on studying past and present price action to predict the probability of Sk Biopharmaceutica's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sk Biopharmaceutica's price. Additionally, you may evaluate how the addition of Sk Biopharmaceutica to your portfolios can decrease your overall portfolio volatility.
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
CEOs Directory
Screen CEOs from public companies around the world
Portfolio Diagnostics
Use generated alerts and portfolio events aggregator to diagnose current holdings
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets